Sponsored by the University of Maryland School of Medicine

Department of Emergency Medicine

EMERGENCY MEDICINE GRAND ROUNDS AND CONFERENCE SERIES

Wednesday 04/16/08
9:30 AM

SEPSIS 2008 - IS YOUR ED PROVIDING THE BEST EVIDENCE-BASED CARE?


Speaker:

Mike Winters,MD
University of Maryland


Learning Objectives:
Upon completion of this activity, participants should be able to:
- Discuss pertinent recommendations of the Surviving Sepsis Campaign as it applies to the ED management of patients with sepsis
- List current ED resuscitation goals for the patient with severe sepsis/septic shock
- Identify current controversies regarding the Surviving Sepsis Campaign, recombinant human Activated Protein C, intensive insulin therapy, and corticosteroid use in patients with sepsis

Disclosure:
It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control the educational content of this regularly scheduled series must disclose any relevant financial relationships they have with commercial interests. Any identified conflicts of interest must be resolved prior to speaker's presentation.

The organizers listed below have disclosed no relevant financial relationships with commercial interests: Gentry Wilkerson MD, Sarah Dubbs MD, Michael Bond MD, Semhar Tewelde MD, Janae Yates

The individuals listed below have disclosed relevant financial relationships with commercial interests: NONE

The lecturer, Mike Winters,MD, has no relevant financial relationships to disclose.

University of Maryland School of Medicine Office of CME staff members have disclosed no relevant financial relationships.

Accreditation:
The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
The University of Maryland School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Discussion of Off-Label or Investigational Uses or Products:

Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use.